Research Technician at UCL

UK DRI

Contract type
Fixed term Full time
Closing date
26 Nov 2025 12:00 AM
Location
UK DRI at UCL, Queen Square- On site
Salary
£36,433-£41,833per annum

The UK Dementia Research Institute (UK DRI) is the biggest UK initiative supporting research to fill the major knowledge gap in our basic understanding of the diseases that cause dementia.

Research from UK DRI at UCL covers the journey from the patient to the laboratory and back to the patient with improved diagnosis, biomarkers and candidate therapies put to the test.

Based within the UK DRI at UCL, the Fluid Biomarker Lab was set up in 2021 with a vision to create a biomarker platform for the UK DRI and the wider neurodegenerative disease research community that can undertake the larger studies to inform dementia research, clinical trial set-up, and treatments for all neurodegenerative diseases.

The Fluid Biomarker Lab collaborates with national and international laboratories working on neurodegeneration, and have multiple sensitive platforms for biomarker measurements, including the first Alamar Biosciences ARGO HT platform in the UK, a Signature 100 Olink platform, a MesoScale Discovery platform, and four Quanterix Simoa HD-X platforms.

About the role

We are recruiting a Research Technician to join the Biomarker Factory team to ensure that samples for biomarker projects are handled correctly, measured in an accurate and timely manner, and their results reported for sign off.

About you

You will hold a BSc in a Biomedical subject (or equivalent relevant experience), knowledge of immunoassays and the technology used, and general laboratory competence with the ability to use basic lab equipment.

IT proficiency at advanced user level, excellent time management and organisational skills, and good interpersonal skills are also essential.  Experience of running ELISA assays and of working with human samples is desirable, as is an interest in neurodegenerative disease research.

The post is available immediately and funded by the UK Dementia Research Institute for twelve months in the first instance.